• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Purine-Pyrimidine Metabolism, Inborn Errors

Purine-Pyrimidine Metabolism, Inborn Errors - 15 Studies Found

Completed : Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
: Gout
: 2015-07-13
:
  • Drug: RDEA3170 2.5 mg

Completed : DECT Study in Allopurinol-Treated Gout Patients
: Gout
: 2015-03-15
: Procedure: DECT scan
Completed : Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout
: Gout
: 2014-12-31
:
  • Drug: Bucillamine Bucillamine

Completed : Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
:
  • Gout
  • Hyperuricemia

: 2014-11-04
:
  • Drug: URC102 0.25mg
  • Drug: URC102 0.5mg

Completed : RDEA3170 and Allopurinol Combination Study in Gout Subjects
: Gout
: 2014-10-28
:
  • Drug: RDEA3170 10 mg
  • Drug: allopurinol 300

<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.